Hjem › Mycosis fungoides › California
Kliniske studier for Mycosis fungoides i California
11 studier for Mycosis fungoides søker deltakere på steder i California.
Byer i California
Offisiell studietekst (engelsk)
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
- City of Hope Medical Foundation, Duarte
- University of Southern California, Los Angeles
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT04234048A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- City of Hope, Duarte
- University of California, Irvine Medical Center - Hematology/Oncology, Orange
- Stanford University School of Medicine, Stanford
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07192471A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
- City of Hope Medical Center, Duarte
- Stanford Cancer Institute Palo Alto, Palo Alto
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07003100A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
- City of Hope Comprehensive Cancer Cente, Duarte
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06854653Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
- City of Hope Medical Center, Duarte
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT04930653Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
- City of Hope Medical Center, Duarte
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 31. jul. 2026 · NCT03011814Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Chao Family Comprehensive Cancer Center, University of California Irvine, Orange
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. jul. 2026 · NCT06580002Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
- Stanford Cancer Center, Stanford
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. jul. 2026 · NCT04256018A Registry for People With T-cell Lymphoma
- City of Hope Cancer Center (Data collection only), Duarte
- UNIVERSITY OF CALIFORNIA SAN DIEGO (Data collection only), San Diego
- University of California San Francisco (Data collection only), San Francisco
- og 1 flere
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 20. mai 2026 · NCT05978141Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- Stanford University Medical Center, Stanford
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 3. apr. 2026 · NCT03587844ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
- City of Hope, Duarte
- Stanford University, School of Medicine, Palo Alto
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 22. okt. 2025 · NCT02848274Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.